Methylphenidate Hydrochloride Tablet
FDA Label NDC 72162-2087

36 label sections · Submitted to the FDA by Bryant Ranch Prepack · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Methylphenidate Hydrochloride (NDC 72162-2087). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: abuse, misuse, and addiction, 1 indications and usage, 2.1 pre-treatment screening, 2.2 general dosing information, 2.3 dosage reduction and discontinuation, 3 dosage forms and strengths, 4 contraindications, 5.1 abuse, misuse, and addiction, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Methylphenidate Hydrochloride Tablets 20 mg

Label (Lbl721622087)

Label (Lbl721622087)

* Please review the disclaimer below.